Health news today is led by a significant shift in diabetes care, with the NHS set to offer teplizumab in England and Wales as the first treatment approved to delay the onset of type 1 diabetes. Backed by NICE and hailed by Diabetes UK as the start of a “new era,” the drug is expected to give some at-risk patients years before full disease develops. Elsewhere, questions of evidence and accountability are shaping two high-profile cases in Australia: in Sydney, a judge has ruled inadmissible the viral video at the center of a case against two nurses accused of threatening Israeli patients, while KPMG Australia is facing fresh turmoil as its chairman and two audit partners exit amid confidentiality allegations. In India, Assam’s Class 10 compartment results have been released, opening the door to higher secondary admission for successful students.